$9.10
0.09[1.00%]
At close: Apr 23
$9.10
0[0.00%]
After Hours: 6:42PM EDT
Talis Biomedical
(NASDAQ:TLIS)Talis Biomedical Stock (NASDAQ:TLIS), Analyst Ratings, Price Targets, Predictions
Talis Biomedical Corp has a consensus price target of $6.5, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from BTIG, BTIG, and B of A Securities on August 16, 2023, March 18, 2022, and March 16, 2022. With an average price target of $2.5 between BTIG, BTIG, and B of A Securities, there's an implied -72.53% downside for Talis Biomedical Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
BTIG
B of A Securities
JP Morgan
Piper Sandler
JP Morgan
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Talis Biomedical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/16/2023 | TLIS | Buy Now | Talis Biomedical | $9.10 | -45.05% | BTIG | Mark Massaro | $0.35 → $5 | Maintains | Sell | Get Alert |
| 03/18/2022 | TLIS | Buy Now | Talis Biomedical | $9.10 | -89.01% | BTIG | Mark Massaro | → $15 | Downgrade | Neutral → Sell | Get Alert |
| 03/16/2022 | TLIS | Buy Now | Talis Biomedical | $9.10 | -83.52% | B of A Securities | Derik De Bruin | $45 → $22.5 | Maintains | Underperform | Get Alert |
| 01/07/2022 | TLIS | Buy Now | Talis Biomedical | $9.10 | -67.03% | B of A Securities | Derik De Bruin | → $45 | Downgrade | Neutral → Underperform | Get Alert |
| 09/27/2021 | TLIS | Buy Now | Talis Biomedical | $9.10 | -23.08% | JP Morgan | Tycho Peterson | — | Downgrade | Neutral → Underweight | Get Alert |
| 08/12/2021 | TLIS | Buy Now | Talis Biomedical | $9.10 | -1.1% | Piper Sandler | Steven Mah | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/11/2021 | TLIS | Buy Now | Talis Biomedical | $9.10 | 9.89% | JP Morgan | — | — | Downgrade | Overweight → Neutral | Get Alert |
FAQ
What is the target price for Talis Biomedical (TLIS)?
The latest price target for Talis Biomedical (NASDAQ: TLIS) was reported by BTIG on August 16, 2023. The analyst firm set a price target for $5.00 expecting TLIS to fall to within 12 months (a possible -45.05% downside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Talis Biomedical (TLIS)?
The latest analyst rating for Talis Biomedical (NASDAQ: TLIS) was provided by BTIG, and Talis Biomedical maintained their sell rating.
When was the last upgrade for Talis Biomedical (TLIS)?
There is no last upgrade for Talis Biomedical.
When was the last downgrade for Talis Biomedical (TLIS)?
The last downgrade for Talis Biomedical Corp happened on March 18, 2022 when BTIG changed their price target from N/A to $1 for Talis Biomedical Corp.
When is the next analyst rating going to be posted or updated for Talis Biomedical (TLIS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Talis Biomedical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Talis Biomedical was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
Is the Analyst Rating Talis Biomedical (TLIS) correct?
While ratings are subjective and will change, the latest Talis Biomedical (TLIS) rating was a maintained with a price target of $0.35 to $5.00. The current price Talis Biomedical (TLIS) is trading at is $9.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.